总时间（秒）：14.98
问答时间（秒）：12.80

Here is the extracted information in the specified JSON format:

```json
{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.5:c.542G>A",
          "cDNA Change": {
            "transcript": "NM_000345.5",
            "ref": "G",
            "alt": "A",
            "position": "542"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "D",
            "position": "181"
          },
          "Description in input context": "c.542G>A (p.G181D)"
        },
        {
          "HGVS": "NM_000345.5:c.468A>G",
          "cDNA Change": {
            "transcript": "NM_000345.5",
            "ref": "A",
            "alt": "G",
            "position": "468"
          },
          "Protein Change": {
            "ref": "D",
            "alt": "E",
            "position": "156"
          },
          "Description in input context": "c.468A>G (p.D156E)"
        },
        {
          "HGVS": "NM_000345.5:c.488T>A",
          "cDNA Change": {
            "transcript": "NM_000345.5",
            "ref": "T",
            "alt": "A",
            "position": "488"
          },
          "Protein Change": {
            "ref": "L",
            "alt": "M",
            "position": "163"
          },
          "Description in input context": "c.488T>A (p.L163M)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson disease",
    "MONDO": "MONDO:0005696"
  },
  "Experiment Method": [
    {
      "Assay Method": "In vitro assay using the 20S proteasome and liposomes",
      "Material used": {
        "Material Source": "Protein expression in E. coli",
        "Material Name": "α-synuclein protein",
        "Description": ""
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.5:c.542G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "acceleration of amyloid fibril formation",
          "Result Description": "The 20S proteasome accelerated the fragmentation and oligomerization of α-synuclein, leading to the formation of cytotoxic oligomers."
        },
        {
          "Variant": "NM_000345.5:c.468A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "acceleration of amyloid fibril formation",
          "Result Description": ""
        },
        {
          "Variant": "NM_000345.5:c.488T>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "acceleration of amyloid fibril formation",
          "Result Description": ""
        }
      ],
      "Biological replicates": {
        "Biological replicates": "No",
        "Description": ""
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each experiment was performed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-synuclein protein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": ""
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": ""
      },
      "Statistical analysis method": {
        "Statistical analysis method": "not described"
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "not described",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "not described",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "No"
      }
    }
  ]
}
```

Note: The above JSON object is based on the information provided in the problem statement, and it may not be a comprehensive representation of all possible variations.